The U.S. Food and Drug Administration (FDA) recently released a warning for pregnant mothers regarding a family of medications that includes ibuprofen, naproxen, diclofenac, celecoxib and other nonsteroidal anti-inflammatory drugs (NSAIDs). Read More »

The National Institute of Health (NIH) has recently expanded options for pharmacists to engage in their Loan Repayment Programs (LRPs), and can apply by Friday, Nov. 20 for this year’s programs. Read More »

Digital Pharmacist's new Rx Confer platform drives revenue for pharmacies while increasing the effectiveness of patient communications. Read More »

Cordant Health Solutions®, a leader in providing innovative tools for monitoring patients in addiction treatment programs, announced that it earned a Net Promoter Score (NPS) of 85 among patients in its managed pharmacy program. Read More »

Several U.S. House Representatives fought to protect access for patients to affordable medicines and the Association for Accessible Medicines (AAM) applauds their effort, according to a news release. Read More »

The American Pharmacists Association (APhA) has partnered with Washington State University College of Pharmacy and Pharmaceutical Sciences to launch a program to prepare pharmacists to meet education requirements to administer vaccinations to children ages three to 18, according to a news release on the APhA's website. Read More »

Digital Pharmacist partners with leading insurance provider to offer Medicare Plan Finder tool at no cost to pharmacies or patients Read More »

Arcadia Consumer Healthcare is changing the way consumers improve the appearance of fungus-damaged nails with its new Opti-Nail® Fungal Nail Repair pen. Read More »

The U.S. Food and Drug Administration (FDA) announced the approval of Opdivo (nivolumab) combined with Yervoy (ipilimumab) for first-line treatment of adults who have malignant pleural mesothelioma that cannot use alternative methods for removal such as surgery. Read More »

The U.S. health care system saved $313 billion in 2019 from generics and biosimilar drugs, including $96 billion in Medicare savings and $48.5 billion in savings to Medicaid. Read More »

The U.S. Food and Drug Administration (FDA) recently approved Pfizer’s drug XELJANZ (tofacitinib) for treatment of polyarticular course juvenile idiopathic arthritis (pcJIA). Read More »

The American Society of Health-System Pharmacists (ASHP) recently launched its first National Survey of Health-System Specialty Pharmacy Practice, according to a press release by the ASHP. Read More »

Eli Lilly and Company’s phase 3 monarchE trial of their cancer treatment drug Verzenio® (abemaciclib) has demonstrated a significant decrease risk of breast cancer recurrence for patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) high risk early breast cancer. Read More »

The American Society of Health-System Pharmacists (ASHP) recently released a response to a petition calling for an end to gender inequality in the clinical pharmacy industry. Read More »

Pharmaceutical Research and Manufacturers of America (PhRMA) president and CEO Stephen J. Ubl has issued a statement regarding the administration's choice of the most favored nation policy. Read More »

Pharmaceutical Research and Manufacturers of America President and CEO Stephen Ubl said the biopharmaceutical industry is confident it will beat COVID-19 as it ensures the highest standards in research, testing and manufacturing a vaccine for the virus. Read More »

Dan Leonard formerly president and CEO of the National Pharmaceutical Council (NPC) has been named new president and CEO of the Association for Accessible Medicines, members of the AAM board announced on Aug. 25. Read More »

This year's We Work for Health Champion Awards honors many individuals that have done tremendous work in the health care industry this year, especially with COVID-19 presenting a new and unique situation. Read More »

Expanding Board of Directors to Add to Commercial Expertise Read More »

The American Pharmacists Association and 12 other pharmacy organizations told a special committee of the National Academies of Science, Engineering and Medicine (NASEM) that pharmacists should be given tier 1 priority status in the allocation and distribution of COVID-19 vaccine(s). Read More »